Literature DB >> 18570214

Monocyte chemoattractant protein-1 secreted by adipose tissue induces direct lipid accumulation in hepatocytes.

Sophie Clément1, Cristiana Juge-Aubry, Antonino Sgroi, Stéphanie Conzelmann, Valerio Pazienza, Brigitte Pittet-Cuenod, Christoph A Meier, Francesco Negro.   

Abstract

UNLABELLED: For many years, adipose tissue has been mainly considered as an inert reservoir for storing triglycerides. Since the discovery that adipocytes may secrete a variety of bioactive molecules (hormones, chemokines, and cytokines), an endocrine and paracrine role for white adipose tissue (WAT) in the regulation of energy balance and other physiological processes has been established, particularly with regard to brain and muscle. In contrast, little is known about the interactions of WAT with liver. Hence, we examined the effect of the secretory products of WAT on hepatocytes. Conditioned medium of human WAT explants induced significant steatosis in hepatocyte cell lines. Factor(s) responsible for the conditioned medium-induced steatosis were screened by a battery of blocking antibodies against different cytokines/chemokines shown to be secreted by WAT. In contrast to interleukin-8 and interleukin-6, the monocyte chemoattractant protein-1 was capable of inducing steatosis in hepatocytes in a time-dependent manner at concentrations similar to those found in conditioned medium. Incubation of conditioned medium with antimonocyte chemoattractant protein-1 antibodies prevented triglyceride accumulation. Investigation of the mechanism leading to the triglyceride accumulation showed that both a diminution of apolipoprotein B secretion and an increase in phosphoenolpyruvate carboxykinase messenger RNA may be involved.
CONCLUSION: The monocyte chemoattractant protein-1 secreted by adipose tissue may induce steatosis not only recruiting macrophages but also acting directly on hepatocytes.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18570214     DOI: 10.1002/hep.22404

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  33 in total

1.  Exendin-4 is effective against metabolic disorders induced by intrauterine and postnatal overnutrition in rodents.

Authors:  Hui Chen; David Simar; Katherine Pegg; Sonia Saad; Clovis Palmer; Margaret J Morris
Journal:  Diabetologia       Date:  2013-12-14       Impact factor: 10.122

Review 2.  Chemokines and their receptors play important roles in the development of hepatocellular carcinoma.

Authors:  Chun-Min Liang; Long Chen; Heng Hu; Hui-Ying Ma; Ling-Ling Gao; Jie Qin; Cui-Ping Zhong
Journal:  World J Hepatol       Date:  2015-06-08

Review 3.  Chemokines and hepatocellular carcinoma.

Authors:  Fan Huang; Xiao-Ping Geng
Journal:  World J Gastroenterol       Date:  2010-04-21       Impact factor: 5.742

4.  Dietary walnut reduces hepatic triglyceride content in high-fat-fed mice via modulation of hepatic fatty acid metabolism and adipose tissue inflammation.

Authors:  Youngshim Choi; Mohamed A Abdelmegeed; Mohammed Akbar; Byoung-Joon Song
Journal:  J Nutr Biochem       Date:  2016-01-06       Impact factor: 6.048

5.  Salidroside Inhibits Lipopolysaccharide-ethanol-induced Activation of Proinflammatory Macrophages via Notch Signaling Pathway.

Authors:  Jian-Sha Li; Lu-Yao Fan; Meng-Dan Yuan; Ming-You Xing
Journal:  Curr Med Sci       Date:  2019-07-25

6.  Dietary cocoa ameliorates obesity-related inflammation in high fat-fed mice.

Authors:  Yeyi Gu; Shan Yu; Joshua D Lambert
Journal:  Eur J Nutr       Date:  2013-03-15       Impact factor: 5.614

7.  Therapeutic administration of the direct thrombin inhibitor argatroban reduces hepatic inflammation in mice with established fatty liver disease.

Authors:  Karen M Kassel; Bradley P Sullivan; Wei Cui; Bryan L Copple; James P Luyendyk
Journal:  Am J Pathol       Date:  2012-07-26       Impact factor: 4.307

Review 8.  The immunopathogenesis of alcoholic and nonalcoholic steatohepatitis: two triggers for one disease?

Authors:  Luca Valenti; Anna Ludovica Fracanzani; Silvia Fargion
Journal:  Semin Immunopathol       Date:  2009-05-14       Impact factor: 9.623

9.  CCR2 promotes hepatic fibrosis in mice.

Authors:  Ekihiro Seki; Samuele de Minicis; Sayaka Inokuchi; Kojiro Taura; Katsumi Miyai; Nico van Rooijen; Robert F Schwabe; David A Brenner
Journal:  Hepatology       Date:  2009-07       Impact factor: 17.425

10.  MLK3 promotes metabolic dysfunction induced by saturated fatty acid-enriched diet.

Authors:  Vidya Gadang; Rohit Kohli; Andriy Myronovych; David Y Hui; Diego Perez-Tilve; Anja Jaeschke
Journal:  Am J Physiol Endocrinol Metab       Date:  2013-07-16       Impact factor: 4.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.